Pedersen S E, Ross E M
J Biol Chem. 1985 Nov 15;260(26):14150-7.
Treatment of beta-adrenergic receptor with dithiothreitol (DTT) or other thiol compounds caused its functional activation in the presence or absence of agonist ligands. Such activation was observed in reconstituted unilamellar phospholipid vesicles that contained beta-adrenergic receptors, purified to greater than or equal to 95% homogeneity from turkey erythrocyte plasma membranes, and the stimulatory GTP-binding protein of the adenylate cyclase system (Gs) purified from rabbit liver. Incubation of the vesicles with 2-10 mM DTT at 0 degrees C for 1 h increased the rate (4-5-fold) and the extent (3-4-fold) of activation of Gs by guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding, an effect about equivalent to the addition of beta-adrenergic agonists. Treatment with DTT also markedly potentiated the ability of agonists to stimulate GTP gamma S binding, increasing the initial rate about 10-fold. DTT treatment was as effective as agonist in stimulating GTPase activity, and maximal stimulation was obtained when DTT-treated vesicles were assayed in the presence of agonist. Other thiol compounds produced effects similar to those of DTT but were at least 10-fold less potent. Stimulation of GTP gamma S binding or GTPase activity required active receptor, and treatment of the receptor with DTT prior to reconstitution also increased its efficacy. There was no effect of DTT on Gs alone. Thus, the site of action of DTT appears to be on the beta-adrenergic receptor itself, and the reduction of disulfides and the binding of agonist act synergistically to activate the receptor. DTT treatment made the receptor more labile to thermal denaturation. Inclusion of cholesterol or cholesteryl-hemisuccinate (5-25%) in the vesicles protected the reduced receptor against such denaturation and enhanced its recovery during reconstitution. No effect of cholesterol or cholesteryl-hemisuccinate was observed on the stability of the nonreduced receptor, which was comparable to that observed in native membranes.
在存在或不存在激动剂配体的情况下,用二硫苏糖醇(DTT)或其他硫醇化合物处理β-肾上腺素能受体可导致其功能激活。在重构的单层磷脂囊泡中观察到这种激活,该囊泡含有从火鸡红细胞质膜纯化至纯度大于或等于95%的β-肾上腺素能受体,以及从兔肝中纯化的腺苷酸环化酶系统的刺激性GTP结合蛋白(Gs)。在0℃下将囊泡与2 - 10 mM DTT孵育1小时,可使鸟苷5'-O-(3-硫代三磷酸)(GTPγS)结合激活Gs的速率(4 - 5倍)和程度(3 - 4倍)增加,其效果约等同于添加β-肾上腺素能激动剂。用DTT处理还显著增强了激动剂刺激GTPγS结合的能力,使初始速率增加约10倍。DTT处理在刺激GTP酶活性方面与激动剂一样有效,并且当在激动剂存在下对经DTT处理的囊泡进行测定时可获得最大刺激。其他硫醇化合物产生的效果与DTT类似,但效力至少低10倍。刺激GTPγS结合或GTP酶活性需要活性受体,并且在重构前用DTT处理受体也会提高其效力。DTT对单独的Gs没有影响。因此,DTT的作用位点似乎在β-肾上腺素能受体本身,二硫键的还原和激动剂的结合协同作用以激活受体。DTT处理使受体对热变性更不稳定。在囊泡中加入胆固醇或胆固醇半琥珀酸酯(5 - 25%)可保护还原后的受体免于这种变性,并增强其在重构过程中的回收率。未观察到胆固醇或胆固醇半琥珀酸酯对未还原受体稳定性的影响,其与天然膜中观察到的稳定性相当。